German Sidra, Bhatti Sajid, Waqar Tajammul, Lashari Sajid, Mehmood Maria, Rizwan Anum, Ali Huraira, Taha Yaseen Raja
Nephrology, Sindh Institute of Urology and Transplantation, Karachi, PAK.
Medicine, Jinnah Sindh Medical University, Karachi, PAK.
Cureus. 2025 Jan 1;17(1):e76715. doi: 10.7759/cureus.76715. eCollection 2025 Jan.
Introduction The global prevalence of chronic kidney disease (CKD) is increasing due to diabetes and hypertension, with a substantial number of patients progressing to end-stage renal disease (ESRD) requiring maintenance dialysis. Thyroid dysfunction, particularly hypothyroidism, is common in CKD and ESRD patients but is often underdiagnosed due to symptom overlap with uremia. This study aimed to determine the prevalence of thyroid dysfunction in hemodialysis patients at the Sindh Institute of Urology and Transplantation (SIUT), Karachi. Methods A prospective cross-sectional study was conducted, enrolling 131 patients on maintenance hemodialysis for at least three months. Participants' demographic and clinical data were collected, and blood samples were taken for thyroid function testing using an Access hypersensitive thyroid-stimulating hormone (hTSH) immunoassay system. Statistical analyses were performed using SPSS version 22.0 (IBM Corp., Armonk, NY), with a significance threshold of p < 0.05. Results The total population included in the study was 131. Out of them, 74 (56.5%) were males. The study population had a mean age of 56.4 years. Hypertension and diabetes were the most common comorbidities noticed in 73 (55.7%) and 14 (10.7%) patients, respectively. Hypothyroidism was observed in 27 (20.6%) patients, with 18 (66.7%) of them having overt hypothyroidism. Hyperthyroidism was observed in four (3.1%) patients, all subclinical. Significant risk factors for hypothyroidism included female gender, longer duration on hemodialysis, decreased total leukocyte and platelet counts, and increased serum urea and creatinine levels. Conclusion The study underscores the significant burden of thyroid dysfunction in ESRD patients on hemodialysis, emphasizing the need for regular screening and management to mitigate associated cardiovascular risks and improve patient outcomes. Future studies should explore the long-term benefits of routine thyroid screening and the impact of different dialysis modalities on thyroid function.
引言 由于糖尿病和高血压,慢性肾脏病(CKD)的全球患病率正在上升,大量患者进展为终末期肾病(ESRD),需要维持性透析。甲状腺功能障碍,尤其是甲状腺功能减退,在CKD和ESRD患者中很常见,但由于与尿毒症症状重叠,往往诊断不足。本研究旨在确定卡拉奇信德泌尿学和移植研究所(SIUT)血液透析患者甲状腺功能障碍的患病率。方法 进行了一项前瞻性横断面研究,纳入131例接受维持性血液透析至少三个月的患者。收集参与者的人口统计学和临床数据,并使用Access超敏促甲状腺激素(hTSH)免疫分析系统采集血样进行甲状腺功能检测。使用SPSS 22.0版(IBM公司,纽约州阿蒙克)进行统计分析,显著性阈值为p<0.05。结果 纳入研究的总人口为131人。其中,74人(56.5%)为男性。研究人群的平均年龄为56.4岁。高血压和糖尿病分别是73例(55.7%)和14例(10.7%)患者中最常见的合并症。27例(20.6%)患者出现甲状腺功能减退,其中18例(66.7%)为显性甲状腺功能减退。4例(3.1%)患者出现甲状腺功能亢进,均为亚临床型。甲状腺功能减退的显著危险因素包括女性、血液透析时间较长、总白细胞和血小板计数减少以及血清尿素和肌酐水平升高。结论 该研究强调了ESRD血液透析患者甲状腺功能障碍的重大负担,强调需要定期筛查和管理,以减轻相关心血管风险并改善患者预后。未来的研究应探讨常规甲状腺筛查的长期益处以及不同透析方式对甲状腺功能的影响。